Literature DB >> 15477734

Surface potential and osteoblast attraction to calcium phosphate compounds is affected by selected alkaline hydrolysis processing.

I O Smith1, M J Baumann, L Obadia, J-M Bouler.   

Abstract

This study examines the link(s) between the suspension behavior of calcium deficient apatites (CDAs) and biphasic calcium phosphate (BCP), as measured by the zeta-potential, with respect to both whole bone and osteoblasts. CDA is fabricated by hydrolyzing an acidic CaP such as dicalcium diphosphate dihydrate (DCPD; CaHPO4.2H2O) and has a structure and composition close to bone apatite. Sintering CDA results in the formation of BCP ceramics consisting of mixtures of hydroxyapatite (HA) and beta-tricalcium phosphate (beta-TCP), with the HA/beta-TCP weight ratio proportional to the Ca/P ratio of CDA. The choice of the base for the DCPD hydrolysis allows various ionic partial substitution of the formed CDA. Na for Ca partial substitution is of interest because of the resulting improvement in mechanical properties of the resulting BCP ceramics and NH4OH was used as a negative control. The zeta-potential was measured for these materials and the stability of the ceramic to bone interaction calculated. zeta-potential values decrease for CDA(NH4OH) versus CDA(NaOH) and increase for BCP(NH4OH) versus BCP(NaOH). While results of these analyses indicate that NH4OH and NaOH processed CDA and BCP will likely yield osteoblast attachment in vivo, differences in the zeta-potentials may explain varying degrees of cell attachment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15477734     DOI: 10.1023/B:JMSM.0000036270.68200.97

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  13 in total

Review 1.  Calcium phosphates in oral biology and medicine.

Authors:  R Z LeGeros
Journal:  Monogr Oral Sci       Date:  1991

2.  Osteogenic potential in vitro of human bone marrow cells cultured on macroporous biphasic calcium phosphate ceramic.

Authors:  J Toquet; R Rohanizadeh; J Guicheux; S Couillaud; N Passuti; G Daculsi; D Heymann
Journal:  J Biomed Mater Res       Date:  1999-01

3.  Influence of biphasic calcium phosphate granulometry on bone ingrowth, ceramic resorption, and inflammatory reactions: preliminary in vitro and in vivo study.

Authors:  O Malard; J M Bouler; J Guicheux; D Heymann; P Pilet; C Coquard; G Daculsi
Journal:  J Biomed Mater Res       Date:  1999-07

4.  Zeta potential of bone from particle electrophoresis: solution composition and kinetic effects.

Authors:  R M Kowalchuk; S R Pollack; T A Corcoran
Journal:  J Biomed Mater Res       Date:  1995-01

5.  Mechanisms and structure of the bond between bone and hydroxyapatite ceramics.

Authors:  F B Bagambisa; U Joos; W Schilli
Journal:  J Biomed Mater Res       Date:  1993-08

6.  Interaction of osteogenic cells with hydroxylapatite implant materials in vitro and in vivo.

Authors:  F B Bagambisa; U Joos; W Schilli
Journal:  Int J Oral Maxillofac Implants       Date:  1990       Impact factor: 2.804

7.  Biphasic calcium phosphates: influence of three synthesis parameters on the HA/beta-TCP ratio.

Authors:  J M Bouler; R Z LeGeros; G Daculsi
Journal:  J Biomed Mater Res       Date:  2000-09-15

8.  Elaboration conditions influence physicochemical properties and in vivo bioactivity of macroporous biphasic calcium phosphate ceramics.

Authors:  O Gauthier; J M Bouler; E Aguado; R Z Legeros; P Pilet; G Daculsi
Journal:  J Mater Sci Mater Med       Date:  1999-04       Impact factor: 3.896

9.  In vitro stability predictions for the bone/hydroxyapatite composite system.

Authors:  D A Oppermann; M J Crimp; D M Bement
Journal:  J Biomed Mater Res       Date:  1998-12-05

10.  Morphological studies of pseudowollastonite for biomedical application.

Authors:  P N de Aza; Z B Luklinska; M Anseau; F Guitian; S de Aza
Journal:  J Microsc       Date:  1996-04       Impact factor: 1.758

View more
  3 in total

1.  Effects of long-term alendronate treatment on postmenopausal osteoporosis bone material properties.

Authors:  N Hassler; S Gamsjaeger; B Hofstetter; W Brozek; K Klaushofer; E P Paschalis
Journal:  Osteoporos Int       Date:  2014-10-15       Impact factor: 4.507

2.  Effects of 3 years treatment with once-yearly zoledronic acid on the kinetics of bone matrix maturation in osteoporotic patients.

Authors:  S Gamsjaeger; B Hofstetter; E Zwettler; R Recker; J A Gasser; E F Eriksen; K Klaushofer; E P Paschalis
Journal:  Osteoporos Int       Date:  2012-11-15       Impact factor: 4.507

3.  Bone quality of the newest bone formed after two years of teriparatide therapy in patients who were previously treatment-naïve or on long-term alendronate therapy.

Authors:  B Hofstetter; S Gamsjaeger; F Varga; H Dobnig; J J Stepan; H Petto; I Pavo; K Klaushofer; E P Paschalis
Journal:  Osteoporos Int       Date:  2014-07-19       Impact factor: 4.507

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.